C
CIN Terminal
Cannabis Investor News
A CanIDeal, Inc. Company
J
Live
Loading market data...
Expand
Symbol Name Exchange Last Change Volume Watch
Home Markets Loading…
RYM Equity

RYTHM Inc.

OTCMKTS · RYM

$23.65
+1.59%
Live Price
Price History 5 Years

Analyst Coverage

Cannabis Investor News in-house rating · cin-analyst-v1.0

Neutral Conviction 2/5
45/100 composite
Fundamentals70
Regulatory49
Market15
Editorial30
Composite · trailing 12 months

Rayonier earns a Neutral rating, with a 45.0 composite score and low conviction of 2/5. Fundamentals provide the principal support at 70.0, driven by maximum subscores for year-over-year revenue growth and gross margin. Regulatory contributes a middling 49.0, combining a neutral jurisdiction posture, weak filing cadence, and a stronger enforcement subscore. Editorial registers 30.0 because CIN newsroom coverage contains no recent newsroom or brief activity. Market performance is the clear constraint at 15.0, reflecting the lowest liquidity tier and no reported trading volume. The pillar mix places Rayonier squarely in the Neutral band: commercial growth and gross profitability offset operating losses, stretched finances, limited disclosure activity, and negligible market participation.

Licensed fundamentals data show revenue growth of approximately 23.7% year over year, a pace that supports the 100.0 revenue-growth subscore. Gross margin stands near 68.3%, also earning a 100.0 subscore, but that strength fails to carry through the income statement. Operating margin is negative 30.4%, while net income records an approximately $11.7 million loss and EBITDA records an approximately $14.0 million loss. The resulting 53.6 operating-margin subscore, 36.5 cash-runway subscore, and 0.30 cash-burn ratio reinforce the stretched financial condition despite strong top-line and gross-margin readings. Primary regulatory filings show the latest filing dated June 18, 2026, no events during the latest 90-day period, and only one event across 180 days. That cadence produces a 25.0 subscore, while zero enforcement hits support the stronger 80.0 enforcement result.

The central forward catalyst sits within fundamentals, Rayonier’s strongest pillar. Continued revenue expansion paired with sustained gross margin creates a path toward better operating leverage, but the current negative operating margin and EBITDA loss demonstrate that conversion remains incomplete. Market confirmation also remains absent because institutional pricing feeds show no volume, while CIN newsroom coverage provides no incremental editorial signal. A stronger rating requires growth and gross profitability to translate into materially improved operating performance without worsening the stretched financial profile. The single most important signal to watch is a decisive improvement in operating margin alongside continued revenue growth.

Scored: 2026-09-22Valid through: 2026-11-06Weights: Fundamentals 35% · Regulatory 25% · Market 25% · Editorial 15%
Loading CIN Rating…
Fundamentals SEC & Market Data
Loading fundamentals…
Analyst Consensus
Loading analyst data…
Valuation Multiples
Loading…
Price Statistics
Loading…
Financing Activity
Loading financing data…
Insider Transactions
Loading insider data…
Regulatory Filings
Loading regulator disclosures…
Peer Comparison
Loading peer data…
Institutional DetailIR, corporate, and filing data from CIN enrichment
IR & AgencyInvestor relations
IR / PR agency
Haus Comms
IR email
IR@RYTHMinc.com
IR page
Investor relations
Corporate DetailsCompany profile
Headquarters
2220 HICKS ROAD, SUITE 210, ROLLING MEADOWS, IL, 60008
Phone
855-420-0020
CEO
Benjamin Kovler (Interim CEO)
CFO
Brad Asher
SEC CIK
1800637
Website
Company website
Fundamentals & FinancialsRefreshed nightly from licensed fundamentals data
Market cap
$46.1M
Enterprise value
$94.1M
Price to book
1.28
Price to sales
1.54
EV / EBITDA
-1.73
Revenue (TTM)
$30.0M
Gross profit (TTM)
$20.5M
EBITDA
$-14.0M
Operating margin
-30.4%
Profit margin
-39.0%
Rev growth YoY
2369.5%
Return on equity
-36.4%
Return on assets
-16.8%
EPS (TTM)
$-14.41
Shares outstanding
2.1M
Insider ownership
47.6%
Institutional ownership
10.5%
Beta
9.46
Full-time employees
1
GICS sector
Consumer Defensive
GICS industry
Tobacco
Filings & DisclosuresPrimary sources
Annual report
Latest 10-K
Proxy statement
Latest DEF 14A
Filing portal
SEC EDGAR
See something incorrect or missing?

Help us keep coverage accurate. Submit an update for CIN editorial review.

Submit an update
Complimentary Research
Would you like a deeper analysis on this company?

Request a complimentary, fully customized institutional-quality research report — tailored to your investment thesis.

Request Complimentary Report

Bullish and Bearish Analyst Opinions for RYTHM Inc. (RYM)

Cannabis Investor News aggregates analyst coverage, price targets, insider transactions, SEC filings, and financing activity for RYTHM Inc. (RYM), a cannabis-sector equity listed on OTCMKTS. Use this profile to compare bullish and bearish opinions, monitor Form 4 insider buys and sells, and review the latest quarterly results.

CIN editorial stance: Risk Elevated. Headwinds: deep drawdown, insider selling. (1 bullish signal, 3 bearish signals.)

Latest price: $23.65 (+1.59%) on OTCMKTS.

Historical Price Data

5-year weekly price history, intraday quotes, and 52-week range for RYM are maintained by Cannabis Investor News and refreshed throughout the trading day.